Clinical Trial Update: Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cirtuvivint alone and in combination with ASTX727 in patients with acute myeloid leukemia and myelodysplastic syndrome; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• ASTX727 (cedazuridine/decitabine)
• Cirtuvivint

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: RECRUITING